Cargando…

The kinetics of HTLV-1 proviral load after allogeneic hematopoietic cell transplantation with reduced intensity conditioning regimen; a comparison with that from sibling donors and that from unrelated donors

Detalles Bibliográficos
Autores principales:	Choi, Ilseung, Tanosaki, Ryuji, Utsunomiya, Atae, Suehiro, Yoko, Okamura, Jun, Uike, Naokuni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042519/ http://dx.doi.org/10.1186/1742-4690-11-S1-P19

Ejemplares similares

Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level
por: Uike, Naokuni, et al.
Publicado: (2011)

Prospective studies of allogeneic hema topoietic stem cell transplantation for adult T-cell leukemia-lymphoma
por: Cho, Ilseung, et al.
Publicado: (2015)

Augmentation of donor-derived Tax-specific CTL responses by a novel Tax epitope-specific CD4+ helper T-cells in ATL patients after allogeneic hematopoietic stem cell transplantation
por: Hasegawa, Atsuhiko, et al.
Publicado: (2014)

The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes
por: Suehiro, Youko, et al.
Publicado: (2014)

Functional impairment of Tax-specific but not CMV-specific CTLs in a minor population of asymptomatic HTLV-1-carriers
por: Hasegawa, Atsuhiko, et al.
Publicado: (2011)

Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell transplant compared with matched sibling and unrelated donor
por: Lv, Weiran, et al.
Publicado: (2017)

The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety
por: Parmar, Gaganvir, et al.
Publicado: (2023)

Identification and characterization of a novel enhancer in the HTLV-1 proviral genome
por: Matsuo, Misaki, et al.
Publicado: (2022)

Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kodama, Daisuke, et al.
Publicado: (2020)

Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study
por: Ruggeri, Annalisa, et al.
Publicado: (2016)

Novel genetic variants associated with mortality after unrelated donor allogeneic hematopoietic cell transplantation
por: Hahn, Theresa, et al.
Publicado: (2021)

Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
por: Brissot, Eolia, et al.
Publicado: (2017)

Recruiting unrelated donors for the National Marrow Donor Program.
por: Yanke, D. R.
Publicado: (1990)

LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors
por: Cruz, David, et al.
Publicado: (2023)

Functional impairment of Tax-specific but not cytomegalovirus-specific CD8(+ )T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers
por: Takamori, Ayako, et al.
Publicado: (2011)

Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma
por: Utsunomiya, Atae
Publicado: (2019)

Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation
por: Barkhordar, Maryam, et al.
Publicado: (2021)

No Association between Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia
por: Gadalla, Shahinaz M., et al.
Publicado: (2017)

Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis
por: Mushtaq, Muhammad Umair, et al.
Publicado: (2022)

Management of psychiatric complications in unrelated donor before unrelated peripheral hematopoietic stem cell collections
por: Hequet, Olivier, et al.
Publicado: (2016)

Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia
por: Sheikh, Irtiza N., et al.
Publicado: (2022)

Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
por: Utsunomiya, Atae, et al.
Publicado: (2011)

The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors
por: Koclega, Anna, et al.
Publicado: (2012)

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
por: Dholaria, Bhagirathbhai, et al.
Publicado: (2021)

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission
por: Saraceni, Francesco, et al.
Publicado: (2017)

Unrelated Hematopoietic Stem Cell Donor Matching Probability and Search Algorithm
por: Tiercy, J.-M.
Publicado: (2012)

Donor-derived 47, XXY in an unrelated cord blood transplant recipient
por: Kawaguchi, Kuniki, et al.
Publicado: (2014)

Support of Unrelated Stem Cell Donor Searches by Donor Center-Initiated HLA Typing of Potentially Matching Donors
por: Schmidt, Alexander H., et al.
Publicado: (2011)

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type
por: Mehta, Rohtesh S., et al.
Publicado: (2023)

Possibility of γδ T cell immunotherapy for HTLV-1-infected individuals
por: Sato, Tomoo, et al.
Publicado: (2011)

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
por: Piemontese, Simona, et al.
Publicado: (2017)

The Benefits of the Post-Transplant Cyclophosphamide in Both Haploidentical and Mismatched Unrelated Donor Setting in Allogeneic Stem Cells Transplantation
por: Dybko, Jarosław, et al.
Publicado: (2023)

IFNL4 and donor selection for matched unrelated donor haematopoietic stem-cell transplantation
por: Westervelt, Peter
Publicado: (2020)

Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation
por: Geller, RB, et al.
Publicado: (1997)

Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors
por: Perez, Lia Elena, et al.
Publicado: (2016)

Treosulfan-Based Conditioning Regimen in Sibling and Alternative Donor Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease
por: Marzollo, Antonio, et al.
Publicado: (2017)

Computer Algorithms in the Search for Unrelated Stem Cell Donors
por: Steiner, David
Publicado: (2012)

COVID19 seroconversion in an unrelated stem cell donor
por: Maakaron, Joseph E., et al.
Publicado: (2020)

Allogeneic Lymphocyte Transfer in MHC-Identical Siblings and MHC-Identical Unrelated Mauritian Cynomolgus Macaques
por: Mee, Edward T., et al.
Publicado: (2014)

HLA-A24-restricted HTLV-I-specific CTL response reduces the HTLV-I proviral load but the HLA increases the risk of HAM/TSP
por: Kubota, Ryuji, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6l5n1kb9mnts0amp961lq7467i